Study Evaluating Safety and Tolerability of Allocetra-OTS in Patients With COVID-19
Clinical trial NCT04659304 · UNKNOWN
Trial details
- NCT number
- NCT04659304
- Sponsor
- Enlivex Therapeutics Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-01
- Primary completion
- 2022-09-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.